Identification of cell-surface mannans in a virulent Helicobacter pylori strain. 2010

José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
Departamento de Química, Universidade de Aveiro, Aveiro, Portugal.

With the intent of contributing to a carbohydrate-based vaccine against the gastroduodenal pathogen, Helicobacter pylori, we report here the structure of cell-surface mannans obtained from a virulent strain. Unlike other wild-type strains, this strain was found to express in good quantities this polysaccharide in vitro. Structural analysis revealed a branched mannan formed by a backbone of alpha-(1-->6)-linked mannopyranosyl residues with approximately 80% branching at the O-2 position. The branches were composed of O-2-linked Man residues in both alpha- and beta-configurations: [abstract: see text]. In addition, this strain also expressed cell-surface emblematic H. pylori lipopolysaccharides (LPS) containing partially fucosylated polyLacNAc O-chains. Affinity assays with polymyxin-B and concanavalin A revealed no association between the mannan and the LPS. The described mannans may be implicated in the mediation of host-microbial interactions and immunological modulation.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008351 Mannans Polysaccharides consisting of mannose units. Mannan
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
July 2005, Carbohydrate research,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
February 1995, FEMS immunology and medical microbiology,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
March 1995, FEMS immunology and medical microbiology,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
July 2016, Folia microbiologica,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
October 1994, Infection and immunity,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
May 2005, Journal of medical microbiology,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
December 2012, Interdisciplinary sciences, computational life sciences,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
January 2017, PloS one,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
September 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology,
José A Ferreira, and Nuno F Azevedo, and Maria João Vieira, and Céu Figueiredo, and Brian J Goodfellow, and Mario A Monteiro, and Manuel A Coimbra
June 2006, American heart journal,
Copied contents to your clipboard!